Gap Junction Protein, beta 4, 30.3kDa (GJB4) Peptid
Kurzübersicht für Gap Junction Protein, beta 4, 30.3kDa (GJB4) Peptid (ABIN937160)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- CPSLLVVMHV AYREERERKH HLKHGPNAPS LYDNLSKKRG GLWWTYLLSL
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GJB4 antibody,
Alternative Names: GJB4 control peptide, GJB4 antibody Blocking Peptide, Anti-GJB4 Blocking Peptide, Gap Junction Protein Beta 4 Blocking Peptide, GJB4, GJB-4, GJB 4, GJB-4 Blocking Peptide, GJB 4 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- GJB4 (Gap Junction Protein, beta 4, 30.3kDa (GJB4))
-
Hintergrund
- Connexins are homologous four-transmembrane-domain proteins and major components of gap junctions. The GJB4 gene encodes connexin 30.3 (Cx30.3) A mutation in connexin 30.3 is causally involved in erythrokeratodermia variabilis (EKV), a mostly autosomal dominant disorder of keratinization.
-
Molekulargewicht
- 29 kDa
Target
-